J OB PURPOSE 工 作 目 的

Sum marizes the job’s purpo se or ro le and why it exi sts in the organi zation

概 述 工 作 的 目 的 或 角 色 及 其 在 机 构 内 的 价 值

Field-ba sed po sition respons ible for i mplementation of acti vi t ies for estab li shment of sc ienti f ic l eadersh ip of A straZene c a. This inc lud es de vel opment and en han cement of profess ional re lat ion ships w i th h eal thcare profess ional s, bu il d i ng deep sc ien t i f ic un derstan d ing of A straZene ca compounds. Dr i v ing po siti ve op inions for the sc i enti f ic and cl ini cal v a lue of AZ compounds for pati ents’ ne eds. De l i ver medi cal educat i on a nd cl i n i cal suppo rt to medi cal profess ion a l s, training s a les teams and i n v o l vement in develop ment of brand strate g y. The po s i t ion m ay a l so be involved in re v i ew of product mate r ials and response to medi cal quer ies.

The re a re 4 l e vels in MSL techni c al ro le, i.e. M SL, S r. MS L, E xecut i ve MS L and Principle MSL.

N A TURE & SCOPE 工 作 性 质 及 范 围

(a) Orga n i zation structure 组 织 机 构

(P lea se attac hed an updated organi zat ion cha rt of your team 请 附 上 你 所 属 团 队 的 最 新 结 构 图)

Depend ing on spe c i f ic team structure

- Fun ctional ly reports to 功 能 汇 报

(Plea se s pe c ify p o siti on t itle 请 注 明 职 位 名 称)

Depend ing on s pec ific team structure

- O peration a l ly reports to 运 作 汇 报

Depend ing on s pec ific team structure

( b) Key work ing re lat ionships 主 要 工 作 关 系

- Inte r nal c onta cts w i thin AZ 内 部 联 系 Other Medi c al affai rs fun ction Commerc i al (i.e., Sales, Ma rketing…) Evidence Generation

Ma rket A ccess

Comp l ian ce

- E xternal c onta cts with organi zat i ons outs ide AZ 外 界 联 系

KEE/HCP

Health Care P rofe ss i onals

Study Investi gato rs

Payer Cus tomers and Policy Makers

(c) Job req u i rements

E ss ential

A c ad emic / P rofess ional qua l ifi c ati on

· Ma ster advan ced degree in clinical / life science qu a l ifi c ation or 2+ y ear on re lev ant expe r ien ce of me d i cal aff a i rs in pharma c euti c al company

· Bache lor deg r ee with strong m edi c al background or 4+ y ear relevant expe r i ence of medi c al aff a i rs in pha r maceu t i cal c ompany

Techni c al / ski ll

· Kno w l edge and e xpe r ien ce of the pharmac euti c al industry and t he a r ea of field medi cal li a i sons

· Abi l ity to inte ract a nd man age a r ange of stakeh o lde rs both interna lly and externa l ly

· Kno w l edge of leg i s l ati on re levant to pharmac euti c al s a les and ma rket ing

· Sel f -ma nag eme nt and execut i on a b i l ity

Des i rab le

Unde rstand ing of mul t i p le a spe cts with in Me d i cal Liai sons

E xpe rien ce in t r a i n ing/ consulting

La ngu age abi l ity 语 言 能 力

Fl uent in s poken/ wr itten Eng li sh

Computer li teracy 电 脑 知 识

Fl uent Mi crosoft Off i ce o peration ski lls

R ole and R espo nsib ility

Objectives

Cr itical actions

M easurements

E xternal Med i cal & S c ientific en gagement

Build, enhance and

maintain the engage me nt with scientific leader

· 60% of t i me in fi eld engaging HCPs and external stakehold e rs across t erritory and brands

· Proactively id e nti fy HCPs with high leve ls of scie nti fic exp ertise in local treat me nt practice to collaborate on speci fic m e dical mark eting activities

· De v elopm e nt and imple m e ntation of KEE engage me nt plan in collaboration with line manager. R ev i ew with line ma nager this plan

every quarter, develop KEE visit plan- this includ es pre call v i sit/engage me nt plan with clear objective of the v i sit, k ey points discus sion for

the visit, data to be shared and discu s s ed with

the KEE

· De v elop o wn scie ntific know l e dge for d i scus sion on all aspects of the data to be shared with KEE in a scientific, objecti ve and balanced way through

1:1 discu ssion s. Prepare for such interactions

with p eer group discu ssion s. Res pond to un solicited re que sts for in for mation about unappro ved AZ products or u nappro ved u ses of appro ved products, prese nting s uch in formation in an objective, sc i e ntifically balance d, s ub stantiated mann er. De v e lop database of Key external experts and also pro v i de recom me ndations for ad visory board participation

Quantity

· 60% of a vailable t i me s p e nt m eeting KEEs. (Available time = total days minus holiday s, we ekend s, sickn es s)

· Complete records of KEE visits and regular re view by MSL line ma nager (define routine r ev i ew as monthly for n ew starters and quarterly for non-n ew start ers)

· Coverage/engagement of KEEs versus plan

· Impro v em e nt in a d vocacy sc ore

Quality

· Meeting skills and prese ntation skills based on in field coaching and ass e s s m e nt

· annual role play a sse s s m e nt of capabilities and sc i e ntific knowle dge– u se standard ass e s s m e nt form and m ethodology

· Feedback from KEEs

Build and maintain tru s t-

b ased relation s hips with

external stakehold ers

· Build AZ relation s hip with k ey external stakehold e rs (e.g. patie nt advocacy group s, k ey me dical organ i zation s, hos pital pharmacy). Find opportunities to collaborate with such external stakeholde r s. Pro vide sc i e ntific s upport in CME

e v e nts and through appropriate me dical s pon sors hip s/ partn ers hip

· Act as sci e ntific exp ert in the disease area( s) by prese nting th erap e utic updat es to ext ernal

stakehold e rs

· Quantity of CMEs and Me dical

Spon sors hip v e r s us plan

· Po sitive cu sto mer f e e dback post e v e nts

De v elop or initiate

scie nti fic programs to explore un met me dical n ee ds in priority dise a se area(s)

· Work with HCPs in scie ntific activiti es that h elp ad vance dis ease und erstanding s uch a s:

- Id e ntify and recommend KEEs for Advisory

Boards

- Id e ntify potential s p eak e rs a nd train s p eak e rs as appropriate

- Interact in the field with the me dical comm unity in the context of various me dical projects, such as clin ical trials, ESRs, sc i e ntific exc hange m eetings

- Discu ss potential in v olv e m e nt in LCM

- Res pond to un solicited off lab el qu estions from KEEs

· Able to conduct basic discus s ions on clinical trials in t erms of study d esign and f easi bility

Quantity

· No. of Ad visory Board Me etin gs ve r s us plan

· No. of P2Ps/round t a ble discus sions ve r s us plan

· No. of CMEs v ers us plan

· No. of ESRs com m unicated

Quality

· Positive custom er f ee dback

· In field ob se r vation by line ma nager and coaching form